Loading…
Self-Assembled Lipid Cubic Phase and Cubosomes for the Delivery of Aspirin as a Model Drug
Three-dimensionally organized lipid cubic self-assemblies and derived oil-in-water emulsions called “cubosomes” are attractive for various biotechnological applications due to their ability to be loaded with functional molecules and their associated sustained release properties. Here, we employed bo...
Saved in:
Published in: | Langmuir 2017-09, Vol.33 (38), p.9907-9915 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Three-dimensionally organized lipid cubic self-assemblies and derived oil-in-water emulsions called “cubosomes” are attractive for various biotechnological applications due to their ability to be loaded with functional molecules and their associated sustained release properties. Here, we employed both of these lipid-based systems for the delivery of a model drug, aspirin, under comparable conditions. Studies were performed by varying drug-to-lipid ratio and the type of release medium, water and phosphate buffer saline (PBS). Release rates were determined using UV–vis spectroscopy, and small-angle X-ray scattering was used to confirm the type of self-assembled nanostructures formed in these lipid systems. The release from the bulk lipid cubic phase was sustained as compared to that of dispersed cubosomes, and the release in PBS was more efficient than in water. The tortuosity of the architecture, length of the diffusion pathway, type of nanostructure, and physicochemical interaction with the release media evidently contribute to these observations. This work is particularly important as it is the first report where both of these nanostructured lipid systems have been studied together under similar conditions. This work provides important insights into understanding and therefore controlling the release behavior of lipid-based drug nanocarriers. |
---|---|
ISSN: | 0743-7463 1520-5827 |
DOI: | 10.1021/acs.langmuir.7b02486 |